Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

Jose I Bernardino, Amanda Mocroft, Patrick W Mallon, Cedrick Wallet, Jan Gerstoft, Charlotte Russell, Peter Reiss, Christine Katlama, Stephane De Wit, Laura Richert, Abdel G. Babiker, Antonio Buño, Antonella Castagna, Pierre-Marie Girard, Genevieve Chene, Francois Raffi, Jose R Arribas, NEAT001/ANRS143 Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Agricultural and Biological Sciences

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology